Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

The cholesterol metabolism pathway in Mycobacterium tuberculosis (M. tb) is a potential source of energy as well as secondary metabolite production that is important for survival of M. tb in the host macrophage. Oxidation and isomerization of 3β-hydroxysterols to 4-en-3-ones is requisite for sterol metabolism and the reaction is catalyzed by 3β-hydroxysteroid dehydrogenase (Rv1106c). Three series of 6-azasteroids and 4-azasteroids were employed to define the substrate preferences of M. tb 3β-hydroxysteroid dehydrogenase. 6-Azasteroids with large, hydrophobic side chains at the C17 position are the most effective inhibitors. Substitutions at C1, C2, C4 and N6 were poorly tolerated. Our structure-activity studies indicate that the 6-aza version of cholesterol is the best and tightest binding competitive inhibitor (K(i)=100 nM) of the steroid substrate and are consistent with cholesterol being the preferred substrate of M. tb 3β-hydroxysteroid dehydrogenase.

Knowledge Graph

Similar Paper

Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2008.0
Inhibitory effect of oxygenated cholestan-3β-ol derivatives on the growth of Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2013.0
A Flavin-dependent Monooxygenase from Mycobacterium tuberculosis Involved in Cholesterol Catabolism
Journal of Biological Chemistry 2010.0
Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
Journal of Medicinal Chemistry 2006.0
Chemical synthesis, biological evaluation and structure–activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents
Bioorganic & Medicinal Chemistry 2011.0
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations
Bioorganic & Medicinal Chemistry 2009.0
Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
Journal of Medicinal Chemistry 2014.0
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Bioorganic & Medicinal Chemistry Letters 2009.0